Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DMK

DMK Pharmaceuticals (DMK)

DMK Pharmaceuticals Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DMK
DateTimeSourceHeadlineSymbolCompany
03/21/20241:23PMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
02/07/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
02/06/20249:04AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
02/05/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
01/31/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
01/23/20244:23PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
01/23/20244:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
01/03/20244:03PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
01/03/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
01/03/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
12/21/202311:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
12/21/20237:15AMGlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHINASDAQ:DMKDMK Pharmaceuticals Corporation
12/04/20233:47PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
12/04/20233:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
11/28/20233:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
11/28/20237:05AMGlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
11/15/20233:39PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
11/15/20233:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
11/15/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
11/15/20233:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
11/14/20232:57PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
11/14/20236:30AMGlobeNewswire Inc.DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
11/13/20239:52AMGlobeNewswire Inc.DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023NASDAQ:DMKDMK Pharmaceuticals Corporation
11/02/20233:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
11/02/20233:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
10/30/20236:30AMGlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
10/25/20234:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
10/25/20234:01PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
10/20/20233:15PMGlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
10/19/20234:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:DMK

Your Recent History

Delayed Upgrade Clock